OGN
Price
$7.18
Change
+$0.09 (+1.27%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
1.84B
47 days until earnings call
Intraday BUY SELL Signals
SNY
Price
$48.47
Change
+$0.11 (+0.23%)
Updated
Dec 26, 04:59 PM (EDT)
Capitalization
117.47B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OGN vs SNY

Header iconOGN vs SNY Comparison
Open Charts OGN vs SNYBanner chart's image
Organon & Co
Price$7.18
Change+$0.09 (+1.27%)
Volume$56.07K
Capitalization1.84B
Sanofi ADS
Price$48.47
Change+$0.11 (+0.23%)
Volume$22.19K
Capitalization117.47B
OGN vs SNY Comparison Chart in %
OGN
Daily Signal:
Gain/Loss:
SNY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OGN vs. SNY commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OGN is a Buy and SNY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 27, 2025
Stock price -- (OGN: $7.09 vs. SNY: $48.36)
Brand notoriety: OGN and SNY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: OGN: 31% vs. SNY: 32%
Market capitalization -- OGN: $1.84B vs. SNY: $117.47B
OGN [@Pharmaceuticals: Major] is valued at $1.84B. SNY’s [@Pharmaceuticals: Major] market capitalization is $117.47B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $963.92B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $104.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OGN’s FA Score shows that 3 FA rating(s) are green whileSNY’s FA Score has 1 green FA rating(s).

  • OGN’s FA Score: 3 green, 2 red.
  • SNY’s FA Score: 1 green, 4 red.
According to our system of comparison, OGN is a better buy in the long-term than SNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OGN’s TA Score shows that 3 TA indicator(s) are bullish while SNY’s TA Score has 6 bullish TA indicator(s).

  • OGN’s TA Score: 3 bullish, 3 bearish.
  • SNY’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SNY is a better buy in the short-term than OGN.

Price Growth

OGN (@Pharmaceuticals: Major) experienced а +1.43% price change this week, while SNY (@Pharmaceuticals: Major) price change was +0.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.24%. For the same industry, the average monthly price growth was +1.36%, and the average quarterly price growth was +14.87%.

Reported Earning Dates

OGN is expected to report earnings on Feb 12, 2026.

SNY is expected to report earnings on Jan 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (+1.24% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNY($117B) has a higher market cap than OGN($1.84B). SNY has higher P/E ratio than OGN: SNY (15.65) vs OGN (3.71). SNY YTD gains are higher at: 4.713 vs. OGN (-51.390). SNY has higher annual earnings (EBITDA): 10.1B vs. OGN (1.56B). SNY has more cash in the bank: 8.91B vs. OGN (672M). OGN has less debt than SNY: OGN (8.83B) vs SNY (21.8B). SNY has higher revenues than OGN: SNY (45.9B) vs OGN (6.3B).
OGNSNYOGN / SNY
Capitalization1.84B117B2%
EBITDA1.56B10.1B15%
Gain YTD-51.3904.713-1,090%
P/E Ratio3.7115.6524%
Revenue6.3B45.9B14%
Total Cash672M8.91B8%
Total Debt8.83B21.8B40%
FUNDAMENTALS RATINGS
SNY: Fundamental Ratings
SNY
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
73
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OGNSNY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
50%
Momentum
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
60%
MACD
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
54%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
42%
Advances
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 3 days ago
53%
Declines
ODDS (%)
Bearish Trend 8 days ago
74%
Bearish Trend 12 days ago
48%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
66%
Aroon
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
46%
View a ticker or compare two or three
Interact to see
Advertisement
OGN
Daily Signal:
Gain/Loss:
SNY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DVRUX17.260.08
+0.47%
UBS US Dividend Ruler P
PRKCX7.170.03
+0.42%
PGIM Real Estate Income C
MCVCX9.640.04
+0.42%
Transamerica Mid Cap Value Opps C
PLFMX32.860.10
+0.31%
Principal Large Cap S&P 500 Index R3
TRNEX40.63-0.11
-0.27%
T. Rowe Price New Era I

OGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, OGN has been loosely correlated with BIIB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OGN jumps, then BIIB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
N/A
BIIB - OGN
37%
Loosely correlated
+0.86%
AZN - OGN
37%
Loosely correlated
+0.34%
PFE - OGN
36%
Loosely correlated
+0.60%
NVS - OGN
35%
Loosely correlated
-0.18%
SNY - OGN
35%
Loosely correlated
+0.08%
More

SNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNY has been loosely correlated with SNYNF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if SNY jumps, then SNYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNY
1D Price
Change %
SNY100%
+0.08%
SNYNF - SNY
61%
Loosely correlated
-1.23%
AZN - SNY
54%
Loosely correlated
+0.34%
PFE - SNY
52%
Loosely correlated
+0.60%
NVS - SNY
49%
Loosely correlated
-0.18%
GSK - SNY
48%
Loosely correlated
+0.23%
More